RTSN Retension Pharmaceuticals, Inc. Common Stock · XNAS
17.41 +23.7% as of Oct 19, 13:15 ET
fans
What's happening Live detector signal Generated 13:15 ET
Share structure
Free float
—
latest
Shares out
7.9M
latest detail
Market cap
$110.9M
at ref price
Short interest
—
latest
Float rotation
—
latest snapshot
20d dollar vol
$2.8M
baseline
Supply intelligence
Gap quality
mixed supply · 60
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
microcap supply profile
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-10-19 13:15 ETSignalRetension Pharmaceuticals, Inc. Common Stock is up 23.7%, at 17.41, on $2.1M traded. Score 72. Primary driver: $2.1M traded. Supply intelligence: mixed supply · 60.
2026-10-138-KItem 5.03 — Amendments to charter or bylaws; Item 9.01 — Financial statements and exhibits SEC
2026-10-08EFFECTPotential financing or dilution-related filing. SEC
2026-09-18S-1Potential financing or dilution-related filing. SEC
Latest detector signalscore 72
score 72